Pharmaceuticals 2010, 3(12), 3543-3569; doi:10.3390/ph3123543
Review

Anticoagulation in the Elderly

* email and email
Received: 7 October 2010; in revised form: 7 December 2010 / Accepted: 9 December 2010 / Published: 10 December 2010
(This article belongs to the Special Issue Anticoagulants)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Management of anticoagulation in elderly patients represents a particularly challenging issue. Indeed, this patient population is at high thromboembolic risk, but also at high hemorrhagic risk. Assessment of the benefit-risk balance of anticoagulation is the key point when decisions are made about introducing and/or continuing such treatments in the individual elderly patient. In order to maximise the safety of anticoagulation in the elderly, some specific considerations need to be taken into account, including renal insufficiency, modified pharmacodynamics of anticoagulants, especially vitamin K antagonists, and the presence of multiple comorbidities and concomitant medications. New anticoagulants could greatly simplify and possibly increase the safety of anticoagulation in the elderly in the near future.
Keywords: anticoagulation; elderly patient; vitamin K antagonist; hemorrhagic risk; factor-Xa inhibitor; thrombin inhibitors
PDF Full-text Download PDF Full-Text [240 KB, Updated Version, uploaded 13 December 2010 10:42 CET]
The original version is still available [235 KB, uploaded 10 December 2010 15:01 CET]

Export to BibTeX |
EndNote


MDPI and ACS Style

Robert-Ebadi, H.; Righini, M. Anticoagulation in the Elderly. Pharmaceuticals 2010, 3, 3543-3569.

AMA Style

Robert-Ebadi H, Righini M. Anticoagulation in the Elderly. Pharmaceuticals. 2010; 3(12):3543-3569.

Chicago/Turabian Style

Robert-Ebadi, Helia; Righini, Marc. 2010. "Anticoagulation in the Elderly." Pharmaceuticals 3, no. 12: 3543-3569.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert